Find used auto parts by searching junkyards near you

Yes. When you search junkyards near me, UsedPart.us will be there to help! At UsedPart.us we know all about finding used auto parts, used car parts, and used truck parts. With our help you can find any used auto part you need. Complete our PARTS FINDER form, we will search our database of over 10,000 junk yards, salvage yards, scrap yards, and recycle centers. Therefore, provide you with the lowest price guaranteed for your auto part or car and truck part, all while providing the industry’s best warranty for your peace of mind. UsedPart.us can help you find engines, transmissions, hoods, fuel pumps, truck beds, front nose assembly and more.

Searching for quality used auto parts has never been easier!

Everyone hates being told the used auto parts or used car parts they need is not in stock. Have you ever just wandered, “Are there any junkyards near me?” With our database you can find junkyards in the USA by zip code, you will hear yes! UsedPart.us understands the used auto parts search and processes down to a science, and have implemented various tools to help insure the process for you is a breeze. No matter the type: new, older, classic, muscle, import, or custom made from different parts from different makes and models! We want to help you find the used auto part and used car part you are looking for. Go green and recycle, which will help reduce humans carbon foot print on the earth. You will also see more green in your wallet also which is a win-win.

You get the freedom to find the best price and warranty that best fits your needs. Locate junkyards in the USA by zip code, or by state for used auto parts with the finest quality, it has never been easier. You have the power to source hard to find, quality used auto parts with our network of 8000 + junkyards throughout the United States. You are no longer stuck searching in just one area, because our network of junkyards covers all 50 states. Find junkyards by in the USA by zip code, state, or area code that are close to you very easily at UsedPart.us! Our company strives to provide excellent junkyard locating and used auto part sourcing, nationwide!? We only list junkyards listed with the ARA on our service.

Tips on Buying Used Auto Parts

We always recommend using O’reilly Auto Parts for any NEW auto and truck parts you may need! Try your luck today!

With over 10,300 junkyards in our database you can rest easy knowing you will find quality used auto parts. As part of the Auto Recycler’s Association, any junkyards found in your state will be in good standing. Providing quality, friendly service at an affordable price. Allow UsedPart.us to help you on your “junkyards near me” or “used auto parts near me” search today. When salvage yards work hard for your business you are almost guaranteed to get the best price!

Don’t feel like searching through each individual junkyard near you to find the part you are looking for? UsedPart.us has made it easier on you with our PARTS FINDER form. Locate parts across the country fast and for the best pricing available! We provide the best price for the auto part you are looking for. Review price, condition, warranty information, and other vital information about those quality used auto parts. Another great thing about our services, we that we will locate parts in the dry climate areas, and not in the rust belt or snow beaten states. This helps you rest easy, knowing the auto parts are not rusty or about to fall apart when received. At UsedPart.us we are all about selling customers used quality auto parts at an affordable price.

Don’t waste your time with long hold times, and poorly trained used car part brokers. They aim to make a profit off of you by marking up prices as much as 50%! Cut out the middleman and get the quality used car part you need at the best available price. Therefore, you can save an average of 35% to 50% of the “aftermarket part cost”! We have saved customers hundreds of thousands of dollars over the years with this convenient auto part search form, so why not join in on the savings today!

To get started, click on your state, enter your zip code in the search box provided, to get a map of all the junkyards in your area! The junkyards listed by state will have contact numbers provided along with addresses, and hours of operation when applicable.

You can search junkyards for auto parts in all US states :
Junkyards in louisiana

Here at UsedPart.us, we have taken all of the junkyards in cities located across the United States and compiled them into our vast Junkyards Near Me Database. This vast collection of complied data gives the user complete control over finding junkyards in the city you choose. Not only do you get to choose to search junkyards by city, but within this search you can locate junkyards in distance by miles from your current location or just use your zip code. Each search quickly brings all the information you need up in a single page for a junkyard that fits your match. This information includes the name, street address, city, state and zip code with the telephone number and hours of operation when applicable. Finding junkyards and quality used auto parts has never been easier, so start searching today!

Catalog of Websites for Cleaning and Home Improvement Businesses

If you own a cleaning business or a home improvement business you might want to include your business website to CleaningAds.Online , a new online directory and market for home improvement businesses.

Before you submit your website to directories, you should first know the actual benefits of directory submission. There are number of benefits of directory submission. One of the main benefits of directory submission is highly quality back links. All the search engines consider the number of back links you have.

Business owners and SEO experts alike recognize the importance of directory submissions for increased traffic and sales. It is one of the most affordable SEO options available and offers great opportunities for business promotion. In fact, it is one of the most important factors to consider when developing your business’s internet marketing strategy. When you use directory submissions to increase traffic to your site, you will notice that your search engine ranking increases; and as your ranking increases, so will the amount of traffic on your site. As you can see, directory submission is a win-win prospect that you simply can’t afford to ignore. Here are the top 5 benefits of directory submission for you online business website.

1. One-way links. Search engines place a premium on one-way links rather than reciprocal links, and directories are a great way to obtain those valuable one-way links. Search engines also place great value on links from sites that are well-established and are relevant to your market niche. Since directories allow you to place your listing in the categories that most closely fit with your product or service, you can rest assured that search engines will consider these links relevant. And you have the option of choosing older, more well-established directories that will show search engines that your links come from authoritative websites.

2. Search engine listings. Once you submit your site to a directory and your site is listed, it will only be a matter of days before the major search engines begin listing your URL as well. Robots are constantly searching for new websites and will find your website fast if it is listed in a directory.

3. Keyword relevance. Having your site listed in a web directory can help build keyword relevance, which in turn results in more traffic to your website.

4. Brand awareness. Directory submission is essential for increasing brand awareness.

5. Affordability. Directory submission is one of the most affordable SEO strategies you can find. Many directories will list your site for free, and even those sites that charge to list your site don’t charge a prohibitive amount. Directory submission is easily one of the most economically reasonable ways to address link popularity, brand awareness, and keyword targeting for your website.

One of the drawbacks to directory submission is that is a tedious process. SEO experts and internet marketing professionals have discovered that manual submission to directories is the most efficacious way to complete the directory submission task since each directory has its own rules and regulations for submission. Using submission software runs a great risk of rejection since such software is unable to customize your listing for each directory and can’t choose appropriate categories and subcategories as accurately as a human can. But manual submission can take a lot of time and effort.

If you’re truly committed to using directory submission as an integral part of your overall internet marketing strategy, you may consider utilizing the service of an internet marketing expert. Not only can an internet marketing expert help you determine how best to use directory submissions within your strategy, but he can also tell you which directories to pursue and which to avoid. He will know which niche directories most closely match your product or service, and he can even take care of the directory submission task on your behalf.

Whether you choose to take on the task of directory submissions yourself or hire a professional to do it for you, be sure to take advantage of the benefits of directory submissions. You’ll be glad you did when you see the increased traffic to your site and when you watch your visitors turn into loyal customers!

Harvard University Stem Cell Institute and Hong Kong National Investment have a strong partnership

Hong Kong National Investment and Harvard University Stem Cell Institute have a strong cooperation.

Mr. Brock Reeve, CEO of Harvard Stem Cell Research Institute, is the Chief Investment Officer of Stem Cell and Regenerative Medisun at National Investment and Medici Medical Group.

2015-05-11 China Securities Journal

On May 8, 2015, Hong Kong Medisun Regerative Medical Center and National Investment (01227.HK) announced the appointment of Mr. Brock Reeve as the chief stem cell and regenerative medicine investment officer of the two companies.

Mr. Brock Reeve is currently the Executive Director of the Harvard University Stem Cell Institute and has graduated from Yale University and Harvard Business School. Mr. Reeve is solely responsible for the strategy and operations of the Harvard Stem Cell Institute, whose overall goal is to use stem cell biology as a tool and treatment to study and treat major degenerative diseases.

As the Chief Investor of Stem Cell and Regenerative Medicine of Medisun Medical Center, Mr. Brock Reeve will organize and lead a professional investment team to actively select the latest regenerative medicine technologies in overseas markets such as Europe, the United States, and Japan and evaluate their investment value. They will also focus on and invest in the world’s leading stem cell regenerative medicine technology, and actively participate in clinical trials and product commercialization of stem cell technology invested by Medisun Medical Center in Asia.

Medisun Medical Center is the world’s most authoritative investment organization in stem cell and regenerative medicine

As the world’s most authoritative investment organization for stem cells and regenerative medicine, Medisun Medical Center has invested in stem cell treatment technologies including heart, tumor, liver, kidney, AIDS and other diseases, fully demonstrating its investment vision and courage. After working with the Mayo Medical Group in the United States, the Medisun once again joined forces with the Harvard University Stem Cell Institute.

Mr. Danny Wong is both the Chairman of the Medisun Medical Group and National Investment (01227.HK). He has devoted himself to research and investment in the field of stem cells for the past five years. The Medisun currently has more than 300 scientists , medical consultants and investment experts from all over the world. The technologies invested by the group are distributed in Europe, the United States, Japan, Hong Kong and other places, and clinical trials are carried out simultaneously.

China’s first participation in international multi-center global synchronized clinical trials

Medisun Medical Group is committed to bringing the world’s leading stem cell and regenerative medicine technologies to China. The investment in the C-cure stem cell therapy for ischemic heart failure technology, which was invented by Mayo Medical Group, has been clinically tested in Europe and the United States. It will carry out clinical trials in China’s well-known cardiovascular hospitals such as Beijing Anzhen Hospital, Fuwai Cardiovascular Hospital and Shanghai Oriental Hospital with the support of international multi-center policy, giving Chinese hospitals the opportunity to participate in the world’s most advanced stem cell technology clinic. The Medisun also actively promote the commercialization of technology worldwide in the future. Before C-Cure’s great technology and revolutionary products for heart disease were officially launched, Medisun has launched a series of cell regeneration factor products to treat a number of diseases, and the product has entered the market.

Liang Zhen ying visits Harvard University Stem Cell Research Institute and Mr. Brock Reeve to discuss the promotion of stem cell and the development of regenerative medicine industry

Under the general environment of Hong Kong’s adjustment of the whole industry, one of the important measures is to develop the stem cell and regenerative medicine industries. Looking at the huge investment in the stem cell and regeneration field of the Medisun Medical Group, it is revealed that it will inevitably set off a disruptive business model in the market.

The Hong Kong government attaches great importance to the development of stem cells. Following the cooperation with the Caroline Medical School in Sweden, Liang Zhen ying visited the Harvard University Stem Cell Research Institute on May 5 and exchanged views with its Executive Director Brock Reeve to promote the development of the stem cell industry in Hong Kong. This will undoubtedly inject a strong shot into the cooperation between Harvard University and Hong Kong in the field of regenerative medicine. It will promote the promotion of Harvard stem cells in regenerative medicine research and technology in Hong Kong and Asia.

It can be seen that Medisun Medical Group has appointed Mr. Brock Reeve take the helm of the stem cell and regenerative medicine to investment. National Investment (01227.HK), which holds a 30% stake in Medisun Medical Group, is investing in regenerative medicine and the field of stem cells. Mr. Brock Reeve will lead the Medisun Medical Group to become a professional stem cell investment team with global leadership.

The value of the stem cell and regenerative medicine industry under the capital market in China and Hong Kong is immeasurable.

With the upcoming clinical management of stem cells, the development of China’s stem cell and regenerative medicine industry will be unstoppable. Shanghai-Hong Kong Stock Connect and the upcoming Shenzhen-Hong Kong Stock Connect have apparently injected huge sums of money into Hong Kong stocks. The stocks of companies related to the stem cell industry have risen very well, but they are far from satisfactory and far from the technology held by Medisun Medical Center. National Investment (01227.HK), as a shareholder of Medisun Medical Group, is full of confidence in the development of the Group.

Medisun Investment Holdings’ Cardio Biotech plans to enter the US capital market.

Medisun Investment Holdings’ C-cure Stem Cell Therapy for Ischemic Heart Failure has exceeded the number of patients enrolled by the European Food and Drug Administration (EMA) in the Phase III clinical trial in Europe and has been approved by the US Food and Drug Administration (FDA). Enter the third phase of clinical. Cardio, the investment holding company of Medisun, also successfully obtained a new round of financing of 32 million euros in February this year. Its financing quota was oversubscribed and snapped up by European and American institutional investors. Cardio is planning to be listed on the NASDAQ in the United States from the end of May to the beginning of June this year (listed in Belgium and France in 2013), and the large-scale financing plan of Cardio further indicates that the spring of stem cells has really come.

After many years of favor and investment in the field of stem cells and regenerative medicine, and the huge capital investment plan, the Medisun’ next step will be the focus of the market. The capital market’s confidence in its shareholder, National Investment (01227.HK), is already evident in the expectation of its future development.According to analysts, Medisun has planned to launch an overall listing financing plan in Hong Kong in the near future. We believe that Medisun, as a recognized leader in the global stem cell and regenerative medicine field, will surely launch an incredible wave of development in this field.

The News Picture:

P1:

Mr. Brock Reeve is both the chairman of Medisun medical group and National Investment (01227.HK) and a close friend of Mr. Danny Wong during his stay in the United States.They share the same confidence and enthusiasm for stem cell and regenerative medicine.

P2:

Hong Kong Chief Executive Liang Zhen ying visited the Harvard University Stem Cell Institute and exchanged views with the Executive Director, Mr. Brock Reeve, on the development of the stem cell and regenerative medicine industries.

Source: http://www.medisun.hk/

Brock Reeve is the younger brother of the famous American actor Christopher Reeve. Christopher Reeve (September 25, 1952 – October 10, 2004), a New Yorker, famous movie actor, film director, writer, was play in Superman (Kal-El/Clark Kent). He graduated from Cornell University in 1974 with a Bachelor of Arts degree and then entered the Juilliard School in New York. He is also a good friend with another famous actor Robin Williams. In 1978, he starred in the sci-fi film “Superman” for the first time and became a hit. In 1995, an accident occurred during an equestrian competition. The spine was seriously injured and his body was paralyzed. Since then, he has devoted himself to social welfare undertakings and to promote stem cell research. He often holds tour lectures. On October 9, 2004, he died for the myocardial infarction at the age of 52.

Hong Kong National Investment and Harvard University Stem Cell Institute starting a high quality cooperation

Hong Kong National Investment and Harvard University Stem Cell Institute have a strong cooperation.

Mr. Brock Reeve, CEO of Harvard Stem Cell Research Institute, is the Chief Investment Officer of Stem Cell and Regenerative Medisun at National Investment and Medici Medical Group.

2015-05-11 China Securities Journal

On May 8, 2015, Hong Kong Medisun Regerative Medical Center and National Investment (01227.HK) announced the appointment of Mr. Brock Reeve as the chief stem cell and regenerative medicine investment officer of the two companies.

Mr. Brock Reeve is currently the Executive Director of the Harvard University Stem Cell Institute and has graduated from Yale University and Harvard Business School. Mr. Reeve is solely responsible for the strategy and operations of the Harvard Stem Cell Institute, whose overall goal is to use stem cell biology as a tool and treatment to study and treat major degenerative diseases.

As the Chief Investor of Stem Cell and Regenerative Medicine of Medisun Medical Center, Mr. Brock Reeve will organize and lead a professional investment team to actively select the latest regenerative medicine technologies in overseas markets such as Europe, the United States, and Japan and evaluate their investment value. They will also focus on and invest in the world’s leading stem cell regenerative medicine technology, and actively participate in clinical trials and product commercialization of stem cell technology invested by Medisun Medical Center in Asia.

Medisun Medical Center is the world’s most authoritative investment organization in stem cell and regenerative medicine

As the world’s most authoritative investment organization for stem cells and regenerative medicine, Medisun Medical Center has invested in stem cell treatment technologies including heart, tumor, liver, kidney, AIDS and other diseases, fully demonstrating its investment vision and courage. After working with the Mayo Medical Group in the United States, the Medisun once again joined forces with the Harvard University Stem Cell Institute.

Mr. Danny Wong is both the Chairman of the Medisun Medical Group and National Investment (01227.HK). He has devoted himself to research and investment in the field of stem cells for the past five years. The Medisun currently has more than 300 scientists , medical consultants and investment experts from all over the world. The technologies invested by the group are distributed in Europe, the United States, Japan, Hong Kong and other places, and clinical trials are carried out simultaneously.

China’s first participation in international multi-center global synchronized clinical trials

Medisun Medical Group is committed to bringing the world’s leading stem cell and regenerative medicine technologies to China. The investment in the C-cure stem cell therapy for ischemic heart failure technology, which was invented by Mayo Medical Group, has been clinically tested in Europe and the United States. It will carry out clinical trials in China’s well-known cardiovascular hospitals such as Beijing Anzhen Hospital, Fuwai Cardiovascular Hospital and Shanghai Oriental Hospital with the support of international multi-center policy, giving Chinese hospitals the opportunity to participate in the world’s most advanced stem cell technology clinic. The Medisun also actively promote the commercialization of technology worldwide in the future. Before C-Cure’s great technology and revolutionary products for heart disease were officially launched, Medisun has launched a series of cell regeneration factor products to treat a number of diseases, and the product has entered the market.

Liang Zhen ying visits Harvard University Stem Cell Research Institute and Mr. Brock Reeve to discuss the promotion of stem cell and the development of regenerative medicine industry

Under the general environment of Hong Kong’s adjustment of the whole industry, one of the important measures is to develop the stem cell and regenerative medicine industries. Looking at the huge investment in the stem cell and regeneration field of the Medisun Medical Group, it is revealed that it will inevitably set off a disruptive business model in the market.

The Hong Kong government attaches great importance to the development of stem cells. Following the cooperation with the Caroline Medical School in Sweden, Liang Zhen ying visited the Harvard University Stem Cell Research Institute on May 5 and exchanged views with its Executive Director Brock Reeve to promote the development of the stem cell industry in Hong Kong. This will undoubtedly inject a strong shot into the cooperation between Harvard University and Hong Kong in the field of regenerative medicine. It will promote the promotion of Harvard stem cells in regenerative medicine research and technology in Hong Kong and Asia.

It can be seen that Medisun Medical Group has appointed Mr. Brock Reeve take the helm of the stem cell and regenerative medicine to investment. National Investment (01227.HK), which holds a 30% stake in Medisun Medical Group, is investing in regenerative medicine and the field of stem cells. Mr. Brock Reeve will lead the Medisun Medical Group to become a professional stem cell investment team with global leadership.

The value of the stem cell and regenerative medicine industry under the capital market in China and Hong Kong is immeasurable.

With the upcoming clinical management of stem cells, the development of China’s stem cell and regenerative medicine industry will be unstoppable. Shanghai-Hong Kong Stock Connect and the upcoming Shenzhen-Hong Kong Stock Connect have apparently injected huge sums of money into Hong Kong stocks. The stocks of companies related to the stem cell industry have risen very well, but they are far from satisfactory and far from the technology held by Medisun Medical Center. National Investment (01227.HK), as a shareholder of Medisun Medical Group, is full of confidence in the development of the Group.

Medisun Investment Holdings’ Cardio Biotech plans to enter the US capital market.

Medisun Investment Holdings’ C-cure Stem Cell Therapy for Ischemic Heart Failure has exceeded the number of patients enrolled by the European Food and Drug Administration (EMA) in the Phase III clinical trial in Europe and has been approved by the US Food and Drug Administration (FDA). Enter the third phase of clinical. Cardio, the investment holding company of Medisun, also successfully obtained a new round of financing of 32 million euros in February this year. Its financing quota was oversubscribed and snapped up by European and American institutional investors. Cardio is planning to be listed on the NASDAQ in the United States from the end of May to the beginning of June this year (listed in Belgium and France in 2013), and the large-scale financing plan of Cardio further indicates that the spring of stem cells has really come.

After many years of favor and investment in the field of stem cells and regenerative medicine, and the huge capital investment plan, the Medisun’ next step will be the focus of the market. The capital market’s confidence in its shareholder, National Investment (01227.HK), is already evident in the expectation of its future development.According to analysts, Medisun has planned to launch an overall listing financing plan in Hong Kong in the near future. We believe that Medisun, as a recognized leader in the global stem cell and regenerative medicine field, will surely launch an incredible wave of development in this field.

The News Picture:

P1:

Mr. Brock Reeve is both the chairman of Medisun medical group and National Investment (01227.HK) and a close friend of Mr. Danny Wong during his stay in the United States.They share the same confidence and enthusiasm for stem cell and regenerative medicine.

P2:

Hong Kong Chief Executive Liang Zhen ying visited the Harvard University Stem Cell Institute and exchanged views with the Executive Director, Mr. Brock Reeve, on the development of the stem cell and regenerative medicine industries.

Source: http://www.medisun.hk/

Brock Reeve is the younger brother of the famous American actor Christopher Reeve. Christopher Reeve (September 25, 1952 – October 10, 2004), a New Yorker, famous movie actor, film director, writer, was play in Superman (Kal-El/Clark Kent). He graduated from Cornell University in 1974 with a Bachelor of Arts degree and then entered the Juilliard School in New York. He is also a good friend with another famous actor Robin Williams. In 1978, he starred in the sci-fi film “Superman” for the first time and became a hit. In 1995, an accident occurred during an equestrian competition. The spine was seriously injured and his body was paralyzed. Since then, he has devoted himself to social welfare undertakings and to promote stem cell research. He often holds tour lectures. On October 9, 2004, he died for the myocardial infarction at the age of 52.